• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

tau蛋白磷酸化和截断与阿尔茨海默病病因学的相关性

Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer's Disease.

作者信息

Zhou Yan, Shi Jianhua, Chu Dandan, Hu Wen, Guan Zongyu, Gong Cheng-Xin, Iqbal Khalid, Liu Fei

机构信息

Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education of China, Co-innovation Center of Neuroregeneration, Nantong University, Nantong, China.

Department of Neurochemistry, Inge Grundke-Iqbal Research Floor, New York State Institute for Basic Research in Developmental Disabilities, New York, NY, United States.

出版信息

Front Aging Neurosci. 2018 Feb 6;10:27. doi: 10.3389/fnagi.2018.00027. eCollection 2018.

DOI:10.3389/fnagi.2018.00027
PMID:29472853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5810298/
Abstract

Microtubule (MT) associated protein tau is abnormally hyperphosphorylated and aggregated into paired helical filaments (PHFs), which manifest as neurofibrillary tangles (NFTs) in the brains of individuals with Alzheimer's disease (AD) and related tauopathies. Hyperphosphorylation and truncation of tau have been linked to the progression of the disease. However, the nature of phosphorylation and truncation of tau in AD brain are not very clear. In the present study we investigated the association of phosphorylation and truncation with high-molecular weight oligomers of tau (HMW-tau) in post-mortem AD brain by western blots. We found that tau from AD brain appears as a smear from low molecular weight (LMW) to HMW tau species in western blots developed with pan-tau antibodies. Similar level of LMW-tau was found in AD and control brains, whereas HMW-tau was found in AD brain only. HMW-tau was hyperphosphorylated at multiple sites and not unphosphorylated at Ser46 or Ser198/199/202. HMW-tau was weakly labeled by tau antibodies 43D against a.a. 6-18 and HT7 against a.a. 159-163 of tau, whereas, the C-terminal antibodies, tau46 and tau46.1, strongly labeled HMW-tau. The ratio of HMW-tau/LMW-tau detected by tau antibodies increased as the epitope of the tau antibodies ranges from N-terminal to C-terminal. The level of tau truncated at Asp421 was increased in AD brain, but was poorly associated with the HMW-tau. These findings suggest that tau pathogenesis involves both hyperphosphorylation and dominantly N-terminal truncation of tau in AD.

摘要

微管相关蛋白tau异常高度磷酸化并聚集成双螺旋丝(PHF),在阿尔茨海默病(AD)及相关tau蛋白病患者的大脑中表现为神经原纤维缠结(NFT)。tau蛋白的过度磷酸化和截短与疾病进展有关。然而,AD大脑中tau蛋白磷酸化和截短的本质尚不完全清楚。在本研究中,我们通过蛋白质印迹法研究了死后AD大脑中tau蛋白的磷酸化和截短与高分子量tau寡聚体(HMW-tau)的关系。我们发现,在用泛tau抗体进行蛋白质印迹时,AD大脑中的tau蛋白在低分子量(LMW)到HMW tau种类之间呈现为一条拖尾条带。在AD大脑和对照大脑中发现的LMW-tau水平相似,而HMW-tau仅在AD大脑中发现。HMW-tau在多个位点高度磷酸化,在Ser46或Ser198/199/202处未磷酸化。HMW-tau被针对tau蛋白第6 - 18位氨基酸的tau抗体43D和针对tau蛋白第159 - 163位氨基酸的HT7弱标记,而C末端抗体tau46和tau46.1则强烈标记HMW-tau。随着tau抗体的表位从N末端到C末端,tau抗体检测到的HMW-tau/LMW-tau比值增加。在AD大脑中,在Asp421处截短的tau蛋白水平升高,但与HMW-tau的相关性较差。这些发现表明,在AD中tau蛋白致病机制涉及tau蛋白的过度磷酸化和主要是N末端截短。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f38b/5810298/396603a0de6a/fnagi-10-00027-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f38b/5810298/aa7299f93a96/fnagi-10-00027-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f38b/5810298/c7d7b6471af0/fnagi-10-00027-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f38b/5810298/b4db8d852eaf/fnagi-10-00027-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f38b/5810298/8fbcc8d75e2f/fnagi-10-00027-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f38b/5810298/396603a0de6a/fnagi-10-00027-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f38b/5810298/aa7299f93a96/fnagi-10-00027-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f38b/5810298/c7d7b6471af0/fnagi-10-00027-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f38b/5810298/b4db8d852eaf/fnagi-10-00027-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f38b/5810298/8fbcc8d75e2f/fnagi-10-00027-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f38b/5810298/396603a0de6a/fnagi-10-00027-g0005.jpg

相似文献

1
Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer's Disease.tau蛋白磷酸化和截断与阿尔茨海默病病因学的相关性
Front Aging Neurosci. 2018 Feb 6;10:27. doi: 10.3389/fnagi.2018.00027. eCollection 2018.
2
Pathological Alterations of Tau in Alzheimer's Disease and 3xTg-AD Mouse Brains.阿尔茨海默病和 3xTg-AD 小鼠脑组织中 Tau 的病理改变。
Mol Neurobiol. 2019 Sep;56(9):6168-6183. doi: 10.1007/s12035-019-1507-4. Epub 2019 Feb 8.
3
The relationship between truncation and phosphorylation at the C-terminus of tau protein in the paired helical filaments of Alzheimer's disease.阿尔茨海默病双螺旋丝中 tau 蛋白 C 末端截断和磷酸化的关系。
Front Neurosci. 2015 Feb 11;9:33. doi: 10.3389/fnins.2015.00033. eCollection 2015.
4
PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer's Disease.PHF核心tau蛋白作为阿尔茨海默病中tau蛋白病理改变的潜在起始事件。
Front Cell Neurosci. 2020 Sep 10;14:247. doi: 10.3389/fncel.2020.00247. eCollection 2020.
5
Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease.糖基化在阿尔茨海默病中tau蛋白过度磷酸化的作用
FEBS Lett. 2002 Feb 13;512(1-3):101-6. doi: 10.1016/s0014-5793(02)02228-7.
6
Phosphorylation Activity in the Alzheimer's Disease and Normal Brain is Modulated by Microtubule-Associated Protein, Tau in Vitro.阿尔茨海默病和正常大脑中的磷酸化活性在体外受微管相关蛋白Tau调节。
J Alzheimers Dis. 1999 Oct;1(3):169-182. doi: 10.3233/jad-1999-1304.
7
Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease.tau蛋白血小板与阿尔茨海默病患者的局部脑萎缩相关。
J Alzheimers Dis. 2017;55(4):1595-1603. doi: 10.3233/JAD-160652.
8
Human neuroblastoma SH-SY5Y cells treated with okadaic acid express phosphorylated high molecular weight tau-immunoreactive protein species.用冈田酸处理的人神经母细胞瘤 SH-SY5Y 细胞表达磷酸化的高分子量 tau 免疫反应性蛋白。
J Neurosci Methods. 2019 May 1;319:60-68. doi: 10.1016/j.jneumeth.2018.09.030. Epub 2018 Sep 29.
9
Pathological Tau From Alzheimer's Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau .来自阿尔茨海默病大脑的病理性tau蛋白诱导tau蛋白位点特异性过度磷酸化以及对SDS和还原剂具有抗性的聚集。
Front Aging Neurosci. 2019 Mar 5;11:34. doi: 10.3389/fnagi.2019.00034. eCollection 2019.
10
Glycosylation of microtubule-associated protein tau in Alzheimer's disease brain.阿尔茨海默病大脑中微管相关蛋白tau的糖基化
Acta Neuropathol. 1999 Jun;97(6):635-41. doi: 10.1007/s004010051040.

引用本文的文献

1
Glycogen synthase kinase-3: the master switch driving neurodegeneration in Alzheimer's disease and Parkinson's disease.糖原合酶激酶-3:驱动阿尔茨海默病和帕金森病神经退行性变的主开关。
Arch Toxicol. 2025 Aug 28. doi: 10.1007/s00204-025-04174-1.
2
Autophagy activators normalize aberrant Tau proteostasis and rescue synapses in human familial Alzheimer's disease iPSC-derived cortical organoids.自噬激活剂可使人类家族性阿尔茨海默病诱导多能干细胞衍生的皮质类器官中异常的 Tau 蛋白稳态正常化并挽救突触。
bioRxiv. 2025 Jul 8:2025.06.25.661453. doi: 10.1101/2025.06.25.661453.
3
The Proteoform Landscape of Tau from the Human Brain.

本文引用的文献

1
Tau passive immunization inhibits not only tau but also Aβ pathology.tau蛋白被动免疫不仅能抑制tau蛋白,还能抑制β淀粉样蛋白(Aβ)的病理变化。
Alzheimers Res Ther. 2017 Jan 10;9(1):1. doi: 10.1186/s13195-016-0227-5.
2
Hyperphosphorylation determines both the spread and the morphology of tau pathology.过度磷酸化决定了 tau 病理的扩散和形态。
Alzheimers Dement. 2016 Oct;12(10):1066-1077. doi: 10.1016/j.jalz.2016.01.014. Epub 2016 Apr 28.
3
Tau and neurodegenerative disease: the story so far.tau 与神经退行性疾病:迄今为止的研究进展。
人脑中tau蛋白异构体的全貌
J Proteome Res. 2025 Jun 6;24(6):2916-2925. doi: 10.1021/acs.jproteome.5c00139. Epub 2025 May 20.
4
Alzheimer's disease patient brain extracts induce multiple pathologies in novel vascularized neuroimmune organoids for disease modeling and drug discovery.阿尔茨海默病患者脑提取物在新型血管化神经免疫类器官中诱发多种病理变化,用于疾病建模和药物发现。
Mol Psychiatry. 2025 May 2. doi: 10.1038/s41380-025-03041-w.
5
Loss of calcium/calmodulin-dependent protein kinase kinase 2, transferrin, and transferrin receptor proteins in the temporal cortex of Alzheimer's patients postmortem is associated with abnormal iron homeostasis: implications for patient survival.阿尔茨海默病患者死后颞叶皮质中钙/钙调蛋白依赖性蛋白激酶激酶2、转铁蛋白和转铁蛋白受体蛋白的缺失与铁稳态异常有关:对患者生存的影响。
Front Cell Dev Biol. 2024 Nov 28;12:1469751. doi: 10.3389/fcell.2024.1469751. eCollection 2024.
6
Tau accumulation is cleared by the induced expression of VCP via autophagy.通过自噬诱导 VCP 的表达来清除 Tau 积累。
Acta Neuropathol. 2024 Sep 24;148(1):46. doi: 10.1007/s00401-024-02804-z.
7
Proteolysis of tau by granzyme A in tauopathies generates fragments that are aggregation prone.颗粒酶 A 在 tau 病中的 tau 蛋白水解产生易于聚集的片段。
Biochem J. 2024 Sep 18;481(18):1255-1274. doi: 10.1042/BCJ20240007.
8
Endogenous tau released from human cultures by neuronal activity is phosphorylated at multiple sites.通过神经元活动从人类培养物中释放的内源性tau蛋白在多个位点发生磷酸化。
bioRxiv. 2024 Jun 2:2024.06.02.597022. doi: 10.1101/2024.06.02.597022.
9
The Enigma of Tau Protein Aggregation: Mechanistic Insights and Future Challenges.tau 蛋白聚集之谜:机制见解与未来挑战。
Int J Mol Sci. 2024 May 2;25(9):4969. doi: 10.3390/ijms25094969.
10
Western Blot of Tau Protein from Mouse Brains Extracts: How to Avoid Signal Artifacts.从鼠脑提取物中进行 Tau 蛋白的 Western Blot:如何避免信号假象。
Methods Mol Biol. 2024;2754:309-321. doi: 10.1007/978-1-0716-3629-9_16.
Nat Rev Neurol. 2016 Jan;12(1):15-27. doi: 10.1038/nrneurol.2015.225. Epub 2015 Dec 4.
4
Tau in physiology and pathology.tau 在生理学和病理学中的作用。
Nat Rev Neurosci. 2016 Jan;17(1):5-21. doi: 10.1038/nrn.2015.1. Epub 2015 Dec 3.
5
SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination.K340位点的小泛素样修饰蛋白化通过失调tau蛋白的磷酸化和泛素化来抑制其降解。
Proc Natl Acad Sci U S A. 2014 Nov 18;111(46):16586-91. doi: 10.1073/pnas.1417548111. Epub 2014 Nov 5.
6
Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.天冬酰胺内肽酶介导的 tau 裂解介导阿尔茨海默病的神经纤维病理。
Nat Med. 2014 Nov;20(11):1254-62. doi: 10.1038/nm.3700. Epub 2014 Oct 19.
7
The acetylation of tau inhibits its function and promotes pathological tau aggregation.tau 蛋白乙酰化会抑制其功能,并促进病理性 tau 聚集。
Nat Commun. 2011;2:252. doi: 10.1038/ncomms1255.
8
Acetylation of tau inhibits its degradation and contributes to tauopathy.tau 乙酰化抑制其降解,导致 tau 病。
Neuron. 2010 Sep 23;67(6):953-66. doi: 10.1016/j.neuron.2010.08.044.
9
Tau truncation is a productive posttranslational modification of neurofibrillary degeneration in Alzheimer's disease.tau 截断是阿尔茨海默病神经纤维缠结中一种具有生产能力的翻译后修饰。
Curr Alzheimer Res. 2010 Dec;7(8):708-16. doi: 10.2174/156720510793611556.
10
Proteolytic processing of tau.tau 蛋白的蛋白水解加工。
Biochem Soc Trans. 2010 Aug;38(4):955-61. doi: 10.1042/BST0380955.